Cannabinoids as Therapeutics

Front Cover
Raphael Mechoulam
Springer Science & Business Media, Mar 30, 2006 - Medical - 268 pages

In recent years, cannabis research has concentrated on the potential of cannabinoids as therapeutic substances, particularly in serious chronic illnesses such as multiple sclerosis. Most volumes published on cannabinoids so far concentrate on the biological activity, biochemistry and pharmacology, whereas this volume concentrates on the diseases, the physiological effects and therapeutic use of cannabinoids. The volume editor Prof. Mechoulam was the first who isolated the prime active constituent (THC, Tetrahydrocannabiol) of marijuana. He published extensively on the pharmacological activities of cannabinoids. The volume is of interest to researchers and clinicians from pharmacology, neuroscience, and medicinal research.

 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

Lumír O Hanuš and Raphael Mechoulam
23
Roger G Pertwee
47
VI
64
Mauro Maccarrone
67
José Antonio Ramos Departamento de Bioquímica y Biología Molecular
79
Stephen A Varvel and Aron H Lichtman
111
Richard E Musty
141
Luciano De Petrocellis Maurizio Bifulco Alessia Ligresti
165
Linda A Parker Cheryl L Limebeer and Magdalena Kwiatkowska
183
Itai A
201
Daniela Parolaro and Tiziana Rubino
207
Murielle RinaldiCarmona Sanofiaventis 371 rue du Professeur Joseph
219
Geoffrey W Guy and Colin G Stott
231
Index
265
Copyright

Other editions - View all

Common terms and phrases

Bibliographic information